Martín-Arévalo, José
Moro-Valdezate, David http://orcid.org/0000-0003-0425-8677
Pla-Martí, Vicente
García-Botello, Stephanie
Moya-Marcos, Pablo
Izquierdo-Moreno, Ana
Pérez-Santiago, Leticia
Casado-Rodrigo, David
Roselló-Keränen, Susana
Espí-Macías, Alejandro
Funding for this research was provided by:
Universitat de Valencia
Article History
Received: 3 April 2023
Accepted: 20 October 2023
First Online: 26 October 2023
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and it was approved by the Institutional Review Board of the University Clinic Hospital of Valencia. Informed consent was waived because of the observational nature of the study and the analysis used anonymous clinical data.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:– David Moro-Valdezate reports a relationship with Johnson and Johnson and Medtronic that include paid expert testimony and reports a relationship with Sanofi that includes travel reimbursement.– José Martín-Arévalo reports a relationship with Johnson and Johnson and Medtronic that include paid expert testimony.– Vicente Pla-Martí reports a relationship with Johnson and Johnson, Medtronic and B Braun Medical Inc. that include consulting or advisory and paid expert testimony and a relationship with Takeda Pharmaceutical Co. Ltd. that includes travel reimbursement.– Stephanie García-Botello reports a relationship with Johnson and Johnson that includes paid expert testimony.– Ana Izquierdo-Moreno reports a relationship with Johnson and Johnson that includes funding grants.– Leticia Pérez-Santiago reports a relationship with Johnson and Johnson that includes funding grants.– Alejandro Espí-Macías reports a relationship with Johnson and Johnson that includes paid expert testimony.